[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$13sh](/topic/$13sh) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Well. personally I think it's more complicated than that. Not necessarily long only. Could be loading up on $CORZ as part of an arb strategy against wider AI/HPC universe. Eg $CORZ has a "floor" from NPV of contracts at call it $13/sh but unlimited upside (if $CRWV rips). So you get AI-like exposure on the right tail and a floor value on the left. Could be useful" [X Link](https://x.com/penny_ether/status/1978859309418332327) [@penny_ether](/creator/x/penny_ether) 2025-10-16T16:23Z 10.7K followers, XXX engagements "📢 M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 💵 Cash-and-stock deal valued at about $700m 📈 $13/sh (53% premium over ATXS last close) 💉 Adds navenibart long-acting injectable for HAE currently in Ph3 🤝 To close in Q1 2026 See image for more info 👇" [X Link](https://x.com/BiopharmIQ/status/1978111044066111699) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-14T14:49Z 27.4K followers, 5357 engagements "@rhysdiab Agree w/ this but cautious as I had same view of $JIN at what was (then) a 5-year P/E low of 19x ($13/sh) thread below for posterity. Market keeps pushing it down I think b/c: - SaaS not ramping fast enough - sunset on $TLC deal 15x could become 10x" [X Link](https://x.com/mondyinvest/status/1977974184237281681) [@mondyinvest](/creator/x/mondyinvest) 2025-10-14T05:46Z 4033 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Well. personally I think it's more complicated than that. Not necessarily long only. Could be loading up on $CORZ as part of an arb strategy against wider AI/HPC universe. Eg $CORZ has a "floor" from NPV of contracts at call it $13/sh but unlimited upside (if $CRWV rips). So you get AI-like exposure on the right tail and a floor value on the left. Could be useful"
X Link @penny_ether 2025-10-16T16:23Z 10.7K followers, XXX engagements
"📢 M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 💵 Cash-and-stock deal valued at about $700m 📈 $13/sh (53% premium over ATXS last close) 💉 Adds navenibart long-acting injectable for HAE currently in Ph3 🤝 To close in Q1 2026 See image for more info 👇"
X Link @BiopharmIQ 2025-10-14T14:49Z 27.4K followers, 5357 engagements
"@rhysdiab Agree w/ this but cautious as I had same view of $JIN at what was (then) a 5-year P/E low of 19x ($13/sh) thread below for posterity. Market keeps pushing it down I think b/c: - SaaS not ramping fast enough - sunset on $TLC deal 15x could become 10x"
X Link @mondyinvest 2025-10-14T05:46Z 4033 followers, XXX engagements
/topic/$13sh/posts